Kinney Horn
Corporate Officer/Principal at IMMUNOME, INC.
Net worth: 24 162 $ as of 2024-04-29
Profile
Kinney Horn is currently the Chief Business Officer at Immunome, Inc. He previously worked as the Director of Business Development at Genentech, Inc. from 2003 to 2019 and as the Chief Business Officer at Olema Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Horn holds a graduate degree from Georgetown University and an undergraduate degree from the University of Mary Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-01-31 | 2,458 ( 0.00% ) | 24 162 $ | 2024-04-29 |
Kinney Horn active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 2024-01-31 |
Former positions of Kinney Horn
| Companies | Position | End |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-03-23 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2019-03-31 |
Training of Kinney Horn
| University of Mary Washington | Undergraduate Degree |
| Georgetown University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Kinney Horn
